Previously, shRNA-mediated inhibition of SAE2, or its binding partner SAE1, in HMECs overexpressing a MYC-oestrogen receptor fusion transgene was shown to induce spindle defects, polyploidy, apoptosis and tumour regression [25]. The gene discussed is MYC; the disease is neoplasm.